Finance

Lists
Why is BBIO up 2,59%?
Dive Deeper
BBIO:NASDAQ
BridgeBio Pharma Inc
64,94 $
+2,59%
(+1,64) 1D
65,30 $
+0,55% (+0,36)
After hours
Closed: 14 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBIO...
Open
63,34 $
High
65,36 $
Low
62,86 $
Mkt. cap
12,70 մլրդ
Avg. vol.
2,74 մլն
Volume
2,70 մլն
52-wk high
93,42 $
52-wk low
52,75 $
EPS
-3,57 $
Beta
0,97
Shares outstanding
195,49 մլն
No. of employees
1 հզր
Open
63,34 $
High
65,36 $
Low
62,86 $
Mkt. cap
12,70 մլրդ
Avg. vol.
2,74 մլն
Volume
2,70 մլն
52-wk high
93,42 $
52-wk low
52,75 $
EPS
-3,57 $
Beta
0,97
Shares outstanding
195,49 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1 հզր
Founded2015
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitebridgebio.com
Analyst ratings
Based on 17 analysts giving stock ratings to BBIO in the past 3 months
Strong buy
Buy
16
Hold
1
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for BBIO in the last 3 months.
Highest
Current 64,94 $
156,00 $ (+140,22%)
Average
111,38 $ (+71,51%)
Lowest
94,00 $ (+44,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
120,00 $
+84,8%
10/14/2026
Luca Issi
RBC Capital
Buy
Maintained
100,00 $
+54%
10/08/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
106,00 $
+63,2%
10/06/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
104,00 $
+60,1%
10/06/2026
Eliana Merle
Barclays
Buy
Maintained
156,00 $
+140,2%
10/07/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
10/06/2026
Tyler Van Buren
TD Cowen
Buy
Reiterated
110,00 $
+69,4%
09/24/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
130,00 $
+100,2%
09/14/2026
Salim Syed
Mizuho Securities
Buy
Maintained
110,00 $
+69,4%
08/31/2026
Andrew Tsai
Jefferies
Buy
Maintained
110,00 $
+69,4%
08/31/2026
Biren Amin
Piper Sandler
Buy
Maintained
115,00 $
+77,1%
08/31/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
110,00 $
+69,4%
08/29/2026
Eric Joseph
Citi
Hold
Maintained
94,00 $
+44,7%
08/12/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
111,00 $
+70,9%
08/12/2026
Danielle Brill
Truist Financial
Buy
Maintained
107,00 $
+64,8%
08/12/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
97,00 $
+49,4%
08/11/2026
Derek Archila
Wells Fargo
Buy
Reiterated
102,00 $
+57,1%
08/11/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
102,00 $
+57,1%
08/11/2026
Tiago Fauth
Raymond James
Buy
Maintained
98,00 $
+50,9%
06/17/2026
Martin Auster
Raymond James
Hold
Downgraded
-
-
05/26/2026
Unknown Analyst
Citi
Hold
Initiated
-
-
05/19/2026
William Pickering
Bernstein
Buy
Reiterated
114,00 $
+75,5%
05/08/2026
Paul Choi
Goldman Sachs
Buy
Maintained
116,00 $
+78,6%
05/08/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
05/02/2026
Lisa Walter
RBC Capital
Buy
Initiated
100,00 $
+54%
04/08/2026
Trevor Allred
Oppenheimer
Buy
Maintained
81,00 $
+24,7%
02/25/2026
Next call 14 օրից
հոկ 28, չրք, 22:30
Fiscal period
Q3 2026
- / -0,58 $
Revenue / Est. (USD)
- / 283,37 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
120,70 մլն
154,18 մլն
194,52 մլն
243,68 մլն
Cost of goods sold
6,56 մլն
8,11 մլն
9,94 մլն
15,05 մլն
Cost of revenue
6,56 մլն
8,11 մլն
9,94 մլն
15,05 մլն
Research and development expenses
112,87 մլն
116,42 մլն
126,64 մլն
149,45 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137,62 մլն
158,08 մլն
163,90 մլն
186,26 մլն
Operating expense
250,50 մլն
274,50 մլն
290,53 մլն
335,71 մլն
Total operating expenses
257,06 մլն
282,61 մլն
300,47 մլն
350,76 մլն
Operating income
-136,36 մլն
-128,43 մլն
-105,96 մլն
-107,08 մլն
Other non operating income
16,46 մլն
11,82 մլն
4,25 մլն
5,59 մլն
EBT including unusual items
-186,48 մլն
-194,76 մլն
-166,56 մլն
-155,89 մլն
EBT excluding unusual items
-177,64 մլն
-183,62 մլն
-166,56 մլն
-155,89 մլն
Income tax expense
-1,54 մլն
-120,00 հզր
-
-
Effective tax rate
0,83%
0,06%
-
-
Other operating expenses
-
-
-
-
Net income
-182,74 մլն
-192,86 մլն
-164,04 մլն
-152,22 մլն
Net profit margin
-151,40%
-125,09%
-84,33%
-62,47%
Earnings per share
-0,72
-0,94
-0,84
-0,78
Interest and investment income
6,24 մլն
4,33 մլն
6,25 մլն
6,66 մլն
Interest expense
-48,15 մլն
-50,31 մլն
-52,82 մլն
-54,62 մլն
Net interest expenses
-41,91 մլն
-45,98 մլն
-46,57 մլն
-47,96 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-134,96 մլն
-127,00 մլն
-104,77 մլն
-106,03 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps